SCHEMBL24543016

SCHEMBL24543016

COCc1ccc(-c2ccc(NC(=O)C(C)(C)Oc3ccc(OC)cc3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 3/20 0.51
▸ PDK1 Q15118 1/20 0.48
▸ PDK2 Q15119 1/20 0.48
▸ PDK3 Q15120 1/20 0.48
▸ PDK4 Q16654 1/20 0.48
▸ SAE1 Q9UBE0 1/20 0.48
▸ UBA2 Q9UBT2 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ POLB P06746 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ LMNA P02545 2/20 0.44
▸ PDE6D O43924 1/20 0.44
▸ S1PR4 O95977 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24543029 0.91 PPARA (0.50) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24542787 0.91 PPARA (0.50) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24542785 0.90 PPARA (0.49) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24542758 0.90 PPARA (0.52) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24542755 0.90 CYP1A2 (0.60) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24542753 0.90 PPARA (0.57) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24543063 0.89 PPARA (0.54) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24542788 0.88 PPARA (0.47) PPARAPDK1PDK2PDK3PDK4
SCHEMBL24543299 0.88 PPARA (0.54) PPARACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24543070 0.88 ALDH1A1 (0.48) PPARACYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4263492-B1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARM INC (US) 2025-04-09 — — EP disclosed
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARMACEUTICALS INC. 2024-04-25 — — US disclosed
WO-2022129933-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 Pandeia Therapeutics Limited (GB) 2022-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 GPR88, GPR65, GPR68 PPARA 355/4885PDK1 3334/4885PDK2 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback